Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Opus Genetics (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited ...

CSHL postdoc Iacopo Gentile has devised a new system for identifying redundant genes and predicting how certain genetic ...

As global temperatures rise, Cold Spring Harbor Laboratory (CSHL) scientists work to grow stronger, more resilient crops. Yet ...

Epicrispr Biotechnologies, a clinical-stage company pioneering gene-modulating therapies, today announced that Amber Salzman, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P.

Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology (MCB) PhD Program jointly ...

In October, Poethig and fellow researcher Aaron Leichty — a former graduate student in Poethig’s lab — published research on ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

The FDA approved Itvisma gene therapy for patients aged 2 years and older with spinal muscular atrophy and confirmed SMN1 ...

Epigenetic regulation plays a central role in shaping the molecular landscape of cancer. Beyond permanent genetic mutations, epigenetic changes provide a ...

An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee ...

With a new study in the journal Cell, researchers at Stanford University and Stockholm University have contributed to ...